These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11922954)

  • 1. Comparative modelling of cytochromes P450.
    Kirton SB; Baxter CA; Sutcliffe MJ
    Adv Drug Deliv Rev; 2002 Mar; 54(3):385-406. PubMed ID: 11922954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure conservation in cytochromes P450.
    Mestres J
    Proteins; 2005 Feb; 58(3):596-609. PubMed ID: 15617063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modelling human cytochromes P450 involved in drug metabolism from the CYP2C5 crystallographic template.
    Lewis DF
    J Inorg Biochem; 2002 Sep; 91(4):502-14. PubMed ID: 12237218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Computer modeling the cytochrome P450 three-dimensional structure: problems and prospects].
    Ivanov AS; Skvortsov VS; Sechenykh AA; Dubanov AV; Lisitsa AV
    Biomed Khim; 2003; 49(3):221-37. PubMed ID: 14564732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer modeling of 3D structures of cytochrome P450s.
    Chang YT; Stiffelman OB; Loew GH
    Biochimie; 1996; 78(8-9):771-9. PubMed ID: 9010606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and function of cytochromes P450: a comparative analysis of three crystal structures.
    Hasemann CA; Kurumbail RG; Boddupalli SS; Peterson JA; Deisenhofer J
    Structure; 1995 Jan; 3(1):41-62. PubMed ID: 7743131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in cytochrome P450 active site modeling.
    Kemp CA; Maréchal JD; Sutcliffe MJ
    Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural flexibility and functional versatility of mammalian P450 enzymes.
    Negishi M; Uno T; Darden TA; Sueyoshi T; Pedersen LG
    FASEB J; 1996 May; 10(7):683-9. PubMed ID: 8635685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P450BM-3; a tale of two domains--or is it three?
    Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
    Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional modelling of human cytochrome P450 1A2 and its interaction with caffeine and MeIQ.
    Lozano JJ; López-de-Briñas E; Centeno NB; Guigó R; Sanz F
    J Comput Aided Mol Des; 1997 Jul; 11(4):395-408. PubMed ID: 9334905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by X-ray crystallography and NMR.
    Gay SC; Roberts AG; Halpert JR
    Future Med Chem; 2010 Sep; 2(9):1451-68. PubMed ID: 21103389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modeling of mammalian cytochrome P450s.
    Friedman FK; Robinson RC; Dai R
    Front Biosci; 2004 Sep; 9():2796-806. PubMed ID: 15353315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring structurally conservative blocks as universal templates for modeling eukaryotic cytochrome P450s.
    Tu Y
    Drug Metabol Drug Interact; 2012; 27(4):235-43. PubMed ID: 23096156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class-dependent sequence alignment strategy improves the structural and functional modeling of P450s.
    Baudry J; Rupasinghe S; Schuler MA
    Protein Eng Des Sel; 2006 Aug; 19(8):345-53. PubMed ID: 16777908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling of mammalian cytochrome P450s.
    Dai R; Pincus MR; Friedman FK
    Cell Mol Life Sci; 2000 Mar; 57(3):487-99. PubMed ID: 10823248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico methods for predicting ligand binding determinants of cytochromes P450.
    de Groot MJ; Kirton SB; Sutcliffe MJ
    Curr Top Med Chem; 2004; 4(16):1803-24. PubMed ID: 15579109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.